These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 4144834)
1. The inhibition of pineal hydroxyindole-O-methyltransferase by haloperidol and fluphenazine. Hartley R; Padwick D; Smith JA J Pharm Pharmacol; 1972 Dec; 24():Suppl:100P-103. PubMed ID: 4144834 [No Abstract] [Full Text] [Related]
7. Inhibitor of indolethylamine N-methyltransferase in pineal extract. Narasimhachari N; Lin RL; Himwich HE Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):375-8. PubMed ID: 4438840 [No Abstract] [Full Text] [Related]
8. The effect of light on the development of a diurnal rhythm in serotonin content and on the development of hydroxyindole-o-methyl transferase activity in the rat pineal gland. Illnerová H Act Nerv Super (Praha); 1972; 14(2):130-1. PubMed ID: 5040162 [No Abstract] [Full Text] [Related]
9. Hydroxyindole-0-methyltransferase. VI. Inhibitory activities of substituted benzoyltryptamines and benzenesulfonyltryptamines. Ho BT; Noel MB; Tansey LW J Pharm Sci; 1971 Apr; 60(4):636-7. PubMed ID: 5166868 [No Abstract] [Full Text] [Related]
10. Purification of bovine pineal hydroxyindole O-methyltransferase by immunoadsorption chromatography. Kuwano R; Yoshida Y; Takahashi Y J Neurochem; 1978 Oct; 31(4):815-24. PubMed ID: 29942 [No Abstract] [Full Text] [Related]
11. Monoclonal antibodies to hydroxyindole O-methyltransferase from bovine pineal gland. Deguchi T; Yokoyama E; Ichikawa T Brain Res; 1987 Jul; 388(2):89-98. PubMed ID: 3113661 [TBL] [Abstract][Full Text] [Related]
12. Action spectra for effects of light on hydroxyindole-o-methyl transferases in rat pineal, retina and harderian gland. Cardinali DP; Larin F; Wurtman RJ Endocrinology; 1972 Oct; 91(4):877-86. PubMed ID: 5051343 [No Abstract] [Full Text] [Related]
13. Immunocytochemical localisation of hydroxyindole-O-methyltransferase in pineal photoreceptor cells of several fish species. Falcón J; Bégay V; Goujon JM; Voisin P; Guerlotté J; Collin JP J Comp Neurol; 1994 Mar; 341(4):559-66. PubMed ID: 8201028 [TBL] [Abstract][Full Text] [Related]
14. Potential inhibitor of S-adenosylmethionine-dependent methyltransferases. 2. Modification of the base portion of S-adenosylhomocysteine. Borchardt RT; Huber JA; Wu YS J Med Chem; 1974 Aug; 17(8):868-73. PubMed ID: 4845380 [No Abstract] [Full Text] [Related]
15. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 1. Modification of the amino acid portion of S-adenosylhomocysteine. Borchardt RT; Wu YS J Med Chem; 1974 Aug; 17(8):862-8. PubMed ID: 4845379 [No Abstract] [Full Text] [Related]
16. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia. Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346 [TBL] [Abstract][Full Text] [Related]
17. Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia. Baron M; Gruen R; Levitt M; Kane J Biol Psychiatry; 1982 Nov; 17(11):1339-42. PubMed ID: 6129906 [No Abstract] [Full Text] [Related]